LUMELung1_3C: LUMELung1, figure 3C

LUMELung1_3CR Documentation

LUMELung1, figure 3C

Description

Kaplan-Meier digitized data from LUMELung1, figure 3C (PMID 24411639). A reported sample size of 655 for a primary endpoint of PFS in lung cancer.

Usage

LUMELung1_3C

Format

A data frame of 1,314 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (docetaxel_nintedanib, docetaxel_placebo)

Source

Reck M, Kaiser R, Mellemgaard A, et al. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. Lancet Oncol 2014; 15: 143–55.

Examples

summary(LUMELung1_3C)

kmplot(LUMELung1_3C)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.